Literature DB >> 23196059

MicroRNAs as potential biomarkers in human solid tumors.

Jun Shen1, Sanford A Stass, Feng Jiang.   

Abstract

MicroRNAs (miRNAs) regulate the expression of approximately 30% of protein-coding genes. Functions of miRNAs are essential to maintain a steady state of cellular machinery. Dysregulations of miRNAs play pivotal roles in the initiation and progression of malignancies. Abnormal miRNA expressions have been found in a variety of human solid tumors. Furthermore, extracellular miRNAs could circulate in body fluids, and hence show great promise for refining diagnosis and prognosis of cancer. Here we review the progress of analysis of microRNAs as a potential approach for diagnosis and prognosis of solid cancer. We will also discuss obstacles in developing miRNAs as circulating biomarkers.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23196059      PMCID: PMC3552101          DOI: 10.1016/j.canlet.2012.11.001

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  143 in total

Review 1.  Non-coding RNAs: regulators of disease.

Authors:  Ryan J Taft; Ken C Pang; Timothy R Mercer; Marcel Dinger; John S Mattick
Journal:  J Pathol       Date:  2010-01       Impact factor: 7.996

2.  Extensive modulation of a set of microRNAs in primary glioblastoma.

Authors:  S A Ciafrè; S Galardi; A Mangiola; M Ferracin; C-G Liu; G Sabatino; M Negrini; G Maira; C M Croce; M G Farace
Journal:  Biochem Biophys Res Commun       Date:  2005-09-09       Impact factor: 3.575

3.  Unique microRNA molecular profiles in lung cancer diagnosis and prognosis.

Authors:  Nozomu Yanaihara; Natasha Caplen; Elise Bowman; Masahiro Seike; Kensuke Kumamoto; Ming Yi; Robert M Stephens; Aikou Okamoto; Jun Yokota; Tadao Tanaka; George Adrian Calin; Chang-Gong Liu; Carlo M Croce; Curtis C Harris
Journal:  Cancer Cell       Date:  2006-03       Impact factor: 31.743

4.  Regulation of p27Kip1 by miRNA 221/222 in glioblastoma.

Authors:  Jana K Gillies; Ian A J Lorimer
Journal:  Cell Cycle       Date:  2007-05-31       Impact factor: 4.534

5.  Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues.

Authors:  Heidi J Peltier; Gary J Latham
Journal:  RNA       Date:  2008-03-28       Impact factor: 4.942

6.  Suppression of non-small cell lung tumor development by the let-7 microRNA family.

Authors:  Madhu S Kumar; Stefan J Erkeland; Ryan E Pester; Cindy Y Chen; Margaret S Ebert; Phillip A Sharp; Tyler Jacks
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-28       Impact factor: 11.205

7.  Deep sequencing reveals differential expression of microRNAs in favorable versus unfavorable neuroblastoma.

Authors:  Johannes H Schulte; Tobias Marschall; Marcel Martin; Philipp Rosenstiel; Pieter Mestdagh; Stefanie Schlierf; Theresa Thor; Jo Vandesompele; Angelika Eggert; Stefan Schreiber; Sven Rahmann; Alexander Schramm
Journal:  Nucleic Acids Res       Date:  2010-05-13       Impact factor: 16.971

8.  MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins.

Authors:  Kasey C Vickers; Brian T Palmisano; Bassem M Shoucri; Robert D Shamburek; Alan T Remaley
Journal:  Nat Cell Biol       Date:  2011-03-20       Impact factor: 28.824

9.  Repertoire of microRNAs in epithelial ovarian cancer as determined by next generation sequencing of small RNA cDNA libraries.

Authors:  Stacia K Wyman; Rachael K Parkin; Patrick S Mitchell; Brian R Fritz; Kathy O'Briant; Andrew K Godwin; Nicole Urban; Charles W Drescher; Beatrice S Knudsen; Muneesh Tewari
Journal:  PLoS One       Date:  2009-04-23       Impact factor: 3.240

10.  miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.

Authors:  Joachim Silber; Daniel A Lim; Claudia Petritsch; Anders I Persson; Alika K Maunakea; Mamie Yu; Scott R Vandenberg; David G Ginzinger; C David James; Joseph F Costello; Gabriele Bergers; William A Weiss; Arturo Alvarez-Buylla; J Graeme Hodgson
Journal:  BMC Med       Date:  2008-06-24       Impact factor: 8.775

View more
  99 in total

1.  Prognostic value of circulating microRNA-21 in digestive system cancers: a meta-analysis.

Authors:  Ting-Ting Ye; Yin-Long Yang; Xin-Ying Liu; Qian-Qing Ji; Yi-Fei Pan; You-Qun Xiang
Journal:  Int J Clin Exp Med       Date:  2014-04-15

2.  Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis.

Authors:  Ke-Cheng Zhang; Hong-Qing Xi; Jian-Xin Cui; Wei-Song Shen; Ji-Yang Li; Bo Wei; Lin Chen
Journal:  Am J Cancer Res       Date:  2015-01-15       Impact factor: 6.166

3.  Digital PCR quantification of miRNAs in sputum for diagnosis of lung cancer.

Authors:  Ning Li; Jie Ma; Maria A Guarnera; HongBin Fang; Ling Cai; Feng Jiang
Journal:  J Cancer Res Clin Oncol       Date:  2013-11-27       Impact factor: 4.553

4.  Prognostic significance of microRNA-16 expression in human colorectal cancer.

Authors:  Jun Qian; Bin Jiang; Min Li; Juan Chen; Mingzhi Fang
Journal:  World J Surg       Date:  2013-12       Impact factor: 3.352

5.  Bioinformatic and metabolomic analysis reveals miR-155 regulates thiamine level in breast cancer.

Authors:  Sinae Kim; Je-keun Rhee; Hyun Ju Yoo; Hee Jin Lee; Eun Ji Lee; Jong Won Lee; Jong Han Yu; Byung Ho Son; Gyungyup Gong; Sung Bae Kim; Shree Ram Singh; Sei Hyun Ahn; Suhwan Chang
Journal:  Cancer Lett       Date:  2014-12-04       Impact factor: 8.679

6.  Connective tissue growth factor (CCN2) and microRNA-21 are components of a positive feedback loop in pancreatic stellate cells (PSC) during chronic pancreatitis and are exported in PSC-derived exosomes.

Authors:  Alyssa Charrier; Ruju Chen; Li Chen; Sherri Kemper; Takako Hattori; Masaharu Takigawa; David R Brigstock
Journal:  J Cell Commun Signal       Date:  2014-01-26       Impact factor: 5.782

7.  Complexity in regulation of microRNA machinery components in invasive breast carcinoma.

Authors:  Sun Young Kwon; Jae-ho Lee; Bora Kim; Jong-Wook Park; Taeg Kyu Kwon; Sun Hee Kang; Shin Kim
Journal:  Pathol Oncol Res       Date:  2014-02-27       Impact factor: 3.201

8.  Decreased expression of miR-218 is associated with poor prognosis in patients with colorectal cancer.

Authors:  Hong Yu; Guangzhong Gao; Lin Jiang; Lingchuan Guo; Mei Lin; Xiao Jiao; Weiguang Jia; Junxing Huang
Journal:  Int J Clin Exp Pathol       Date:  2013-11-15

9.  Novel blood-based microRNA biomarker panel for early diagnosis of pancreatic cancer.

Authors:  Ganepola Ap Ganepola; John R Rutledge; Paritosh Suman; Anusak Yiengpruksawan; David H Chang
Journal:  World J Gastrointest Oncol       Date:  2014-01-15

10.  miR-326 reverses chemoresistance in human lung adenocarcinoma cells by targeting specificity protein 1.

Authors:  Jipeng Li; Shanfeng Li; Zhe Chen; Jianhua Wang; Ying Chen; Zhengyang Xu; Mingwei Jin; Wanjun Yu
Journal:  Tumour Biol       Date:  2016-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.